 Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. | 
